Jie Tian Selected Research

Cardiomegaly (Heart Hypertrophy)

6/2023	Epigallocatechin-3-gallate restores mitochondrial homeostasis impairment by inhibiting HDAC1-mediated NRF1 histone deacetylation in cardiac hypertrophy.
1/2022	Epigallocatechin-3-gallate exerts cardioprotective effects related to energy metabolism in pressure overload-induced cardiac dysfunction.
1/2022	Treg/Th17 Ratio Regulation May Play an Important Role in Epigallocatechin-3-Gallate-Mediated Attenuation of Increased Afterload-Induced Cardiac Hypertrophy.
1/2019	In utero exposure to PM2.5 during gestation caused adult cardiac hypertrophy through histone acetylation modification.
1/2018	The protective role of low-concentration alcohol in high-fructose induced adverse cardiovascular events in mice.
6/2015	Alcohol-induced histone H3K9 hyperacetylation and cardiac hypertrophy are reversed by a histone acetylases inhibitor anacardic acid in developing murine hearts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Tian Research Topics

Disease

244	Neoplasms (Cancer) 05/2024 - 07/2003
48	Breast Neoplasms (Breast Cancer) 04/2024 - 09/2008
42	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 08/2011
32	Neoplasm Metastasis (Metastasis) 11/2023 - 07/2011
20	Glioma (Gliomas) 05/2024 - 01/2014
16	Stomach Neoplasms (Stomach Cancer) 12/2022 - 01/2013
15	Inflammation (Inflammations) 01/2024 - 01/2011
15	Liver Neoplasms (Liver Cancer) 10/2023 - 01/2014
14	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2017
13	Carcinogenesis 09/2023 - 09/2008
12	Fibrosis (Cirrhosis) 02/2024 - 09/2013
12	Pain (Aches) 01/2024 - 11/2008
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 04/2016
12	Hypoxia (Hypoxemia) 03/2023 - 01/2018
11	Rectal Neoplasms (Rectal Cancer) 01/2024 - 12/2017
11	Nasopharyngeal Carcinoma 11/2023 - 08/2017
11	Pancreatic Neoplasms (Pancreatic Cancer) 05/2023 - 09/2017
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 01/2019
11	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 03/2007
9	Adenocarcinoma 02/2024 - 07/2003
9	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 07/2011
8	COVID-19 02/2024 - 01/2020
8	Infections 07/2023 - 05/2009
8	Body Weight (Weight, Body) 06/2023 - 07/2003
8	Autoimmune Diseases (Autoimmune Disease) 03/2023 - 06/2015
8	Lymphatic Metastasis 01/2023 - 10/2008
7	Carcinoma (Carcinomatosis) 04/2024 - 12/2006
7	Adenocarcinoma of Lung 03/2023 - 07/2011
7	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2012
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 05/2017
7	Disease Progression 01/2021 - 01/2012
7	Ischemia 08/2020 - 01/2012
6	Hyperthermia 03/2024 - 01/2017
6	Cardiomyopathies (Cardiomyopathy) 02/2024 - 10/2006
6	Acute Lung Injury 12/2023 - 03/2004
6	Cardiomegaly (Heart Hypertrophy) 06/2023 - 06/2015
6	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2017
5	Atherosclerosis 06/2023 - 01/2017
5	Rheumatoid Arthritis 03/2023 - 01/2012
5	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2018
5	Obesity 01/2022 - 11/2014
5	Restrictive Cardiomyopathy 04/2020 - 09/2010
5	Experimental Arthritis 01/2020 - 03/2012
4	Mitochondrial Diseases (Mitochondrial Disease) 02/2024 - 01/2021
4	Esophageal Squamous Cell Carcinoma 02/2024 - 11/2021

Drug/Important Bio-Agent (IBA)

56	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2011
32	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2023 - 01/2013
26	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2008
16	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 10/2006
14	Immune Checkpoint InhibitorsIBA 12/2023 - 09/2018
14	Fluorescent Dyes (Fluorescent Probes)IBA 11/2023 - 09/2015
14	Coloring Agents (Dyes)IBA 11/2023 - 07/2013
14	Peptides (Polypeptides)IBA 07/2023 - 03/2007
14	Long Noncoding RNAIBA 05/2023 - 07/2011
14	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2012
12	Therapeutic UsesIBA 12/2022 - 01/2008
12	LigandsIBA 11/2022 - 03/2012
11	Messenger RNA (mRNA)IBA 03/2023 - 09/2008
11	CytokinesIBA 01/2023 - 07/2003
10	GoldIBA 01/2020 - 03/2014
9	Eosine Yellowish-(YS) (Eosin)IBA 03/2024 - 07/2011
9	Tyrosine Kinase InhibitorsIBA 07/2023 - 01/2018
9	Histones (Histone)IBA 06/2023 - 12/2010
8	Molecular Probes (Molecular Probe)IBA 04/2024 - 07/2013
8	ErbB Receptors (EGF Receptor)IBA 04/2024 - 02/2018
8	Contrast MediaIBA 02/2024 - 01/2014
8	RNA (Ribonucleic Acid)IBA 09/2023 - 04/2016
7	Hematoxylin (Haematoxylon)IBA 03/2024 - 07/2011
7	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2013
6	Analgesics (Analgesic Drugs)IBA 01/2024 - 01/2017
6	Indicators and Reagents (Reagents)IBA 12/2023 - 12/2017
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2012
6	CollagenIBA 01/2023 - 10/2018
6	Radioisotopes (Radionuclides)IBA 01/2022 - 04/2011
6	salicylhydroxamic acid (SHAM)IBA 01/2022 - 11/2008
5	LipopolysaccharidesIBA 02/2024 - 01/2003
5	Estrogen ReceptorsIBA 11/2023 - 09/2008
5	Apolipoproteins E (ApoE)IBA 06/2023 - 01/2017
5	AutoantibodiesIBA 01/2023 - 11/2014
5	RadiopharmaceuticalsIBA 07/2021 - 06/2012
5	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 01/2014

Therapy/Procedure

94	Therapeutics 03/2024 - 12/2004
36	Precision Medicine 05/2024 - 01/2014
34	Immunotherapy 05/2024 - 08/2014
28	Drug Therapy (Chemotherapy) 02/2024 - 10/2009
19	Computer-Assisted Surgery (Image Guided Surgery) 04/2024 - 01/2015
19	Neoadjuvant Therapy 12/2023 - 12/2017
18	Photothermal Therapy 01/2023 - 03/2014
15	Lasers (Laser) 01/2024 - 10/2015
13	Intravenous Injections 01/2023 - 03/2010
12	Radiotherapy 04/2024 - 10/2009
8	Hepatectomy 01/2023 - 03/2019
7	Chemoradiotherapy 01/2022 - 12/2017
7	Anesthesia 01/2021 - 01/2016
6	Induction Chemotherapy 08/2021 - 10/2009
6	Aftercare (After-Treatment) 01/2019 - 07/2003
5	Lymph Node Excision (Lymph Node Dissection) 01/2024 - 01/2020
5	Analgesia 11/2023 - 01/2008
5	Hysterectomy 01/2023 - 09/2013
5	Transplantation 01/2021 - 10/2006